[Weekly News]CRISPR/Cas9 Gene Knockout: A New Strategy to Overcome Immune Therapy Resistance in Neur
EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.